Abstract:A biosynthetic pathway was constructed to produce α‐aminoadipate. Multi‐strategy metabolic engineering was used for regulating cell metabolism. Finally, 1.54 g/L of α‐aminoadipate was produced in fed‐batch experiments. As a non‐protein amino acid, α‐aminoadipate is used in the fields of medicine, chemical engineering, food science, and others. For example, α‐aminoadipate is an important precursor for the production of β‐lactam antibiotics. Currently, the synthesis of α‐aminoadipate depends on chemical catalysis that has the disadvantages of high cost, low yield, and serious pollution. In this study, we construct a biosynthesis pathway of α‐aminoadipate in Escherichia coli using lysine as a precursor. In addition, we regulate the cell metabolism to improve the titer of α‐aminoadipate via multi‐strategy metabolic engineering. First, a novel synthetic pathway was constructed to realize de novo synthesis of α‐aminoadipate with titers of 82 mg/L. Second, the key enzymes involved in enhancing precursor synthesis were overexpressed and the CO2 fixation process was introduced, and these led to 80% and 34% increases in the α‐aminoadipate concentration, reaching 147 and 110 mg/L, respectively. Third, cofactor regulation was used to maintain the coupling balance of material and energy, with the intracellular α‐aminoadipate concentration reaching 140 mg/L. Fourth, the weakening of the synthesis of acetic acid was used to strengthen the synthesis of α‐aminoadipate, and this resulted in the enhancement of the α‐aminoadipate concentration by 2.2 times, reaching 263 mg/L. Finally, combination optimization was used to promote the production of α‐aminoadipate. The titers of α‐aminoadipate reached 368 mg/L (strain EcN11#) and 415 mg/L (strain EcN11##), which was 3.5 and 4 times higher than that of the parent strain. With these efforts, 1.54 g/L of α‐aminoadipate was produced under fed‐batch conditions by strain EcN11#. This study is the first to present the effective biosynthesis of α‐aminoadipate in E. coli using multi‐strategy metabolic engineering.

De novo biosynthesis and whole-cell catalytic production of paracetamol on a gram scale in Escherichia coli

Design and construction of an artificial pathway for biosynthesis of acetaminophen in Escherichia coli

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

De novo biosynthesis of α‐aminoadipate via multi‐strategy metabolic engineering in Escherichia coli

Efficient De Novo Biosynthesis of Curcumin in Escherichia coli by Optimizing Pathway Modules and Increasing the Malonyl-CoA Supply

Establishment of Novel Biosynthetic Pathways for the Production of Salicyl Alcohol and Gentisyl Alcohol in Engineered Escherichia coli.

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli

[Metabolic engineering of Escherichia coli for de novo synthesis of 1,4-butanediol]

Sustainable Beckmann Rearrangement using Bead‐Milling Technology: The Route to Paracetamol

De Novo Synthesis of 1-Phenethylisoquinoline in Engineered Escherichia Coli

Metabolic Engineering of Escherichia coli for the Biosynthesis of 3-Phenylpropionic Acid and 3-Phenylpropyl Acetate

Back to the plant: overcoming roadblocks to the microbial production of pharmaceutically important plant natural products

Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B12

Establishing biosynthetic pathway for the production of p-hydroxyacetophenone and its glucoside in Escherichia coli

Engineering Escherichia coli native metabolism for efficient biosynthesis of orotate

A Metabolically Integrated Lossen Rearrangement in Escherichia coli

Metabolic engineering of E. coli for producing phloroglucinol from acetate

Optimization of hydrogenobyrinic acid biosynthesis in Escherichia coli using multi-level metabolic engineering strategies

Optimization of trans-4-hydroxyproline synthesis pathway by rearrangement center carbon metabolism in Escherichia coli

De novo biosynthesis of τ-cadinol in engineered Escherichia coli